SPARC and keloid: In conclusion, our work demonstrated that SPARC could activate the p38γ pathway to stabilize the expression of PFKFB3, and thus promote the glycolysis of KFs and the progression of keloid, implying that SPARC/p38γ/PFKFB3 signaling axis may be a new molecular mechanism in the therapy of keloids.